Skip to main content

Table 3 Univariate and Multivariate cox regression for prostate cancer incidence only among organ-transplanted patients

From: The effect of subsequent immunosuppressant use in organ-transplanted patients on prostate cancer incidence: a retrospective analysis using the Korean National Health Insurance Database

Characteristics

N

Event

Duration

IR (per 1000)

Univariate

Multivariate

HR

p value

HR

p value

Age (years), 20 ≤ Age < 50

6464

7

33,223.01

0.2107

0.088 (0.04,0.192)

< 0.001

0.111 (0.05,0.245)

< 0.001

50 ≤ Age < 65

6077

61

26,552.55

2.29733

1 (Ref.)

 

1 (Ref.)

 

65 ≤ Age ≤ 75

422

9

1537.49

5.85368

2.7 (1.339,5.444)

 

2.809 (1.383,5.708)

 

75 < Age

7

0

18.31

0

0 (0)

 

0 (0)

 

Aspirin Yes

973

7

4371.79

1.60118

1.318 (0.606,2.866)

0.486

1.249 (0.568,2.749)

0.5798

Statin Yes

4312

15

19,924.96

0.75282

0.502 (0.286,0.883)

0.017

1.088 (0.513,2.306)

0.8257

Duration of Immunosuppressant (> 300 days)

11,113

74

56,759.46

1.30375

1.508 (0.473,4.809)

0.488

1.857 (0.581,5.937)

0.2967

Hypertension Yes

8135

40

38,322.42

1.04378

0.648 (0.414,1.013)

0.057

1.213 (0.72,2.043)

0.4685

Diabetes mellitus Yes

6251

48

29,495.66

1.62736

1.79 (1.129,2.838)

0.013

1.296 (0.814,2.063)

0.2747

Dyslipidemia Yes

4085

10

18,540.27

0.53937

0.346 (0.178,0.673)

0.002

0.453 (0.19,1.079)

0.0739

Transplanted organ

        

 1. Kidney

7026

21

33,615.34

0.62471

1 (Ref.)

0.0001

1 (Ref.)

0.3227

 2. Liver

5445

54

25,616.58

2.10801

3.398 (2.053,5.626)

 

2.016 (1.067,3.809)

 

 3. Pancreas

28

0

105.38

0

N.A

 

N.A

 

 4. Heart

398

2

1760.07

1.13632

1.85 (0.434,7.889)

 

1.288 (0.297,5.592)

 

 5. Lung

73

0

233.99

0

N.A

 

N.A

 
  1. NA not available